Does ACALABRUTINIB Cause Disease progression? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Disease progression have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 1.3% of all adverse event reports for ACALABRUTINIB.
122
Reports of Disease progression with ACALABRUTINIB
1.3%
of all ACALABRUTINIB reports
15
Deaths
14
Hospitalizations
How Dangerous Is Disease progression From ACALABRUTINIB?
Of the 122 reports, 15 (12.3%) resulted in death, 14 (11.5%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for ACALABRUTINIB.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which ACALABRUTINIB Alternatives Have Lower Disease progression Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC